Earlier this month, health authorities confirmed that BA.2.86, a highly mutated variant of the virus that causes COVID-19, is at risk of spreading rapidly in countries around the world. With updated shots rolling out this ...
Sep 22, 2023
0
17
COVID-19 patients are often prescribed antiviral drugs that work by reducing the number of viral particles circulating in the body. One such drug, molnupiravir, tricks the virus into generating mutations, some of which are ...
Sep 13, 2023
0
20
Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID.
Sep 11, 2023
0
32
Herpes is not only unpleasant but it can, in some cases, also have dangerous complications and life-threatening consequences. In the journal Angewandte Chemie, a research team has now introduced a completely new approach ...
Sep 7, 2023
0
67
Researchers have developed an automated version of the viral plaque assay, the gold-standard method for detecting and quantifying viruses. The new method uses time-lapse holographic imaging and deep learning to greatly reduce ...
Aug 31, 2023
0
7
While conventional flu vaccines are designed to anticipate the influenza strains projected to dominate in the next flu season, they're only partially effective. And while antiviral drugs are available to treat active flu ...
Aug 15, 2023
0
89
Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission ...
Aug 9, 2023
0
2
Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
The ongoing COVID-19 pandemic has raised global concern on public health. There are major challenges ahead to develop new therapeutics and vaccines for difficult-to-target pathogens, for which we urgently need a better understanding ...
Jul 25, 2023
0
1
Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most ...
Jul 21, 2023
0
11
